Oral contraceptive use and risk of fractures

被引:23
|
作者
Vestergaard, Peter [1 ]
Rejnmark, Lars [1 ]
Mosekilde, Leif [1 ]
机构
[1] Aarhus Univ Hosp, Osteoporosis Clin, Aarhus Amtssygehus, Dept Endocrinol & Metab C, DK-8000 Aarhus C, Denmark
关键词
fracture; oral contraceptives; epidemiology; risk factors; confounders;
D O I
10.1016/j.contraception.2006.01.006
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Introduction: Prior studies have suggested that oral contraceptives (OCs) may be associated with an increased fracture risk. However, the previous studies have only performed a limited adjustment for other potential risk factors. Subjects and Methods: All women with a fracture (n=64,548) in the year 2000 in Denmark served as cases. For each case, three age-matched controls were randomly drawn from the general population (n = 193,641). Exposure was use of OCs between January 1, 1996, and December 31, 2000. Adjustments were made for use of other drugs, pregnancy, prior fracture, other diseases and social variables. Results: In the unadjusted analysis, use of OCs in low dose was associated with a small increase in overall fracture risk. However, upon adjustment, no increase in fracture risk could be demonstrated in any age or dose group. Conclusion: Oral contraceptives are not associated with an increase or a decrease in fracture risk. Any change in fracture risk may be due to confounders. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:571 / 576
页数:6
相关论文
共 50 条
  • [41] Oral contraceptive use and impact of cumulative intake of estrogen and progestin on risk of ovarian cancer
    Faber, M. T.
    Jensen, A.
    Frederiksen, K.
    Glud, E.
    Hogdall, E.
    Hogdall, C.
    Blaakaer, J.
    Kjaer, S. K.
    CANCER CAUSES & CONTROL, 2013, 24 (12) : 2197 - 2206
  • [42] Are oral contraceptive use and pregnancy complications risk factors for atopic disorders among offspring?
    Brooks, K
    Samms-Vaughan, M
    Karmaus, W
    PEDIATRIC ALLERGY AND IMMUNOLOGY, 2004, 15 (06) : 487 - 496
  • [43] A prospective study of reproductive factors and oral contraceptive use in relation to the risk of uterine leiomyomata
    Marshall, LM
    Spiegelman, D
    Goldman, MB
    Manson, JE
    Colditz, GA
    Barbieri, RL
    Stampfer, MJ
    Hunter, DJ
    FERTILITY AND STERILITY, 1998, 70 (03) : 432 - 439
  • [44] Obesity: risk of venous thrombosis and the interaction with coagulation factor levels and oral contraceptive use
    Abdollahi, M
    Cushman, M
    Rosendaal, FR
    THROMBOSIS AND HAEMOSTASIS, 2003, 89 (03) : 493 - 498
  • [45] Oral contraceptive use and impact of cumulative intake of estrogen and progestin on risk of ovarian cancer
    M. T. Faber
    A. Jensen
    K. Frederiksen
    E. Glud
    E. Høgdall
    C. Høgdall
    J. Blaakær
    S. K. Kjær
    Cancer Causes & Control, 2013, 24 : 2197 - 2206
  • [46] The epidemiology of oral contraceptive use: A critical review of the studies on oral contraceptives and the health of young women
    Lewis, MA
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1998, 179 (04) : 1086 - 1097
  • [47] Oral contraceptive use by formulation and breast cancer risk by subtype in the Nurses' Health Study II: a prospective cohort study
    Burchardt, Norah A.
    Eliassen, A. Heather
    Shafrir, Amy L.
    Rosner, Bernard
    Tamimi, Rulla M.
    Kaaks, Rudolf
    Tworoger, Shelley S.
    Fortner, Renee T.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2022, 226 (06) : 821.e1 - 821.e26
  • [48] Hemostatic effects of smoking and oral contraceptive use
    Fruzzetti, F
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1999, 180 (06) : S369 - S374
  • [49] ORAL-CONTRACEPTIVE USE AND GESTATIONAL CHORIOCARCINOMA
    PALMER, JR
    CANCER DETECTION AND PREVENTION, 1991, 15 (01): : 45 - 48
  • [50] COMPARISON OF ORAL-CONTRACEPTIVE USE IN WOMEN WITH ADENOCARCINOMA AND SQUAMOUS-CELL CARCINOMA OF THE UTERINE CERVIX
    HONORE, LH
    KOCH, M
    BROWN, LB
    GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 1991, 32 (02) : 98 - 101